Loading provider…
Loading provider…
Ophthalmology Physician in Greensboro, NC
NPI: 1427172246Primary Employer
Piedmont Eye Surgical and Laser PLLC
piedmonteyedoctor.com
HQ Phone
Get MD Karl's Phone Numberphone_androidMobile
Get MD Karl's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardNC State Medical License
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 92136Measurement of corneal curvature and depth of eye | 102 | 242 |
| 2 | 66984Removal of cataract with insertion of lens | 77 | 137 |
| 3 | 99204New patient office or other outpatient visit, 45-59 minutes | 62 | 62 |
| 4 | 99213Established patient office or other outpatient visit, typically 15 minutes | 57 | 69 |
| 5 | 66821Removal of recurring cataract in lens capsule using laser | 45 | 71 |
Low level light therapy for the treatment of recalcitrant chalazia: a sample case summary.
Authors: Stonecipher, Karl, Potvin, Richard
Journal: Clin Ophthalmol
Publication Date: 2019-09-05
Topography-Guided Refractive Astigmatism Outcomes: Predictions Comparing Three Different Programming Methods.
Authors: Daniel Durrie, Ronald Krueger, Timothy Lindquist, Robert Stulting
Publication Date: 2020-01-02
Lead Sponsor: Surface Ophthalmics, Inc.
Intervention / Treatment: DRUG: Lifitegrast 5% Ophthalmic Solution, DRUG: SURF-100 (Combination of 0.3% Mycophenolic Acid and 0.01% Betamethasone Sodium Phosphate), DRUG: Mycophenolic Acid 0.1%, DRUG: Mycophenolic Acid 0.3%, DRUG: Betamethasone Sodium Phosphate 0.01%, DRUG: Placebo Comparator: Vehicle, DRUG: Cyclosporine 0.05% Ophthalmic Emulsion
Lead Sponsor: AcuFocus, Inc.
Intervention / Treatment: DEVICE: Control Group, DEVICE: IC-8 IOL Group